MUC5B and chronic obstructive pulmonary disease: Consistent with our ELISA findings, measurement by mass spectrometry also showed trends toward increased MUC5B on day 9 compared with baseline that did not reach statistical significance, and no differences were detected between patients with COPD and healthy participants during infection (Supplemental Figure 2C).